Healthy volunteers needed to test two versions of heart drug
NCT ID NCT07476157
First seen Mar 26, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This early-stage study tests two versions of a drug (AD-118 and AD-1181) in 70 healthy adults aged 19-65. Participants receive a single dose of each version in random order, and researchers measure safety and how the drug moves through the body. The goal is to compare the two formulations, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H PLUS YANGJI HOSPITAL, Seoul
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.